Susan Short, one of the researchers involved in this study, said that the team believes that Sativex may be the missing piece in the medical puzzle of treating glioblastoma. Short, who is the Professor of clinical oncology and neuro-oncology, claims that Sativex may be able to kill the tumor cells when it is given with the temozolomide chemotherapy treatment.
Germany has received nearly 900 applications for cannabis cultivation associations, but only just over half…
A Senate stopgap funding bill would delay the federal prohibition on most hemp-derived THC products…
He smokes in boardrooms, but he’s still on that underground frequency. This content originally appeared…
Fox News opinion ran a piece recently from Scott Chipman, vice president of Americans Against…
For our 50th anniversary, we handed the plant to the artists making its most striking…
Corporate valuation increased in 21 of the 38 states studied following medical marijuana legalization. Gross…